Expression of RCAS1 in female genital organs

International Journal of Gynecological Pathology

Volumn 24, Issue 4, 2005, Pages 330-334

  Kawano, Yoshiaki ^a   Kaku, Tsunehisa ^b,c   Sonoda, Kenzo ^c   Hirakawa, Toshio ^c   Kobayashi, Hiroaki ^c   Ohishi, Yoshihiro ^a   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apoptosis; Differentiation; Metaplasia; Normal female genital tract; Receptor binding antigen expressed on a human uterine adenocarcinoma cell line; SiSo

Indexed keywords

ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; RECEPTOR BINDING ANTIGEN EXPRESSED ON HUMAN UTERINE ADENOCARCINOMA CELL LINE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; APOPTOSIS; APOPTOSIS INDEX; ARTICLE; CELL STRAIN; CELL STRAIN SISO; ENDOMETRIUM GLAND; EXOCRINE GLAND; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METAPLASIA; OVARY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SQUAMOUS CELL METAPLASIA; SQUAMOUS EPITHELIUM; TISSUE DIFFERENTIATION; TUMOR GROWTH; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX GLAND; UTERINE TUBE; UTERUS; UTERUS BODY;

ADULT; AGED; AGING; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; APOPTOSIS; ENDOMETRIUM; EPITHELIUM; FALLOPIAN TUBES; FEMALE; GENITALIA, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARY; STROMAL CELLS; UTERUS;

EID: 25444433559     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000165204.37574.a5     Document Type: Article

References (31)

1. Sonoda K, Nakashima M, Kaku T, et al. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996;77:1501-9.
2. Sonoda K, Kaku T, Kamura T, et al. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 1998;4:1517-20.
3. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999;5:938-42.
4. Kaku T, Sonoda K, Kamura T, et al. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 1999;5:1449-53.
5. Iwasaki T, Nakashima M, Watanabe T, et al. Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 2000;89:488-93.
6. Izumi M, Nakanishi Y, Yoshino I, et al. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001;92:446-51.
7. Kubokawa M, Nakashima M, Yao T, et al. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 2001;19:695-700.
8. Noguchi K, Enjoji M, Nakamuta M, et al. Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 2001;168:197-202.
9. Oshikiri T, Hida Y, Miyamoto M, et al. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gall-bladder cancer. Br J Cancer 2001;85:1922-7.
10. Takahashi H, Iizuka H, Nakashima M, et al. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001;26:140-4.
11. Hiraoka K, Hida Y, Miyamoto M, et al. High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker. Int J Cancer 2002;99:418-23.
12. Nakakubo Y, Hida Y, Miyamoto M, et al. The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. Cancer Lett 2002;177:101-5.
13. Oizumi S, Yamazaki K, Nakashima M, et al. RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung. Oncology 2002;62:333-9.
14. Rousseau J, Tetu B, Caron D, et al. RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun 2002;293:1544-9.
15. Suzuoki M, Hida Y, Miyamoto M, et al. RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma. Ann Surg Oncol 2002;9:388-93.
16. Sonoda K, Miyamoto S, Hirakawa T, et al. Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. Br J Cancer 2003;89:546-51.
17. Takahashi S, Urano T, Tsuchiya F, et al. EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer. Int J Cancer 2003;106:310-5.
18. Matsushima T, Nakashima M, Oshima K, et al. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001;98:313-21.
19. Ohshima K, Muta K, Nakashima M, et al. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion. Int J Cancer 2001;93:91-6.
20. Nakamura Y, Yamazaki K, Oizumi S, et al. Expression of RCAS1 in human gastric carcinoma: A potential mechanism of immune escape. Cancer Sci 2004;95:260-5.
21. Aoki T, Inoue S, Imamura H, et al. EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation. Eur J Cancer 2003;39:1552-61.
22. Ito Y, Yoshida H, Nakano K, et al. Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma. Oncology 2003;64:83-9.
23. Sonoda K, Nakashima M, Saito T, et al. Establishment of a new-human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int J Oncol 1995;6:1099-104.
24. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975;122:262-3.
25. Fukuda K, Tsujitani S, Maeta Y, et al. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer 2002;5:220-7.
26. Leelawat K, Watanabe T, Nakajima M, et al. Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer. J Clin Pathol 2003;56:764-8.
27. Okada K, Nakashima M, Komuta K, et al. Expression of tumor-associated membrane antigen, RCAS1, in human colorectal carcinomas and possible role in apoptosis of tumor-infiltrating lymphocytes. Mod Pathol 2003;16:679-85.
28. Akashi T, Oimomi H, Nishiyama K, et al. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas 2003;26:49-55.
29. Morales CP, Souza RF, Spechler SJ. Hallmarks of cancer progression in Barrett's oesophagus. Lancet 2002;360:1587-9.
30. Mirza ZK, Das KK, Slate J, et al. Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut 2003;52:807-12.
31. Boers JE, ten Velde GP, Thunnissen FB. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Am J Respir Crit Care Med 1996;153:411-6.